Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study.
暂无分享,去创建一个
L. Boulet | F. Hargreave | M. Castro | James B. Young | P. Nair | S. Mathur | T. Henkel | F. Xie | H. J. Wilkins | James Young
[1] F. Hargreave,et al. Point: Is measuring sputum eosinophils useful in the management of severe asthma? Yes. , 2011, Chest.
[2] F. Hargreave,et al. Efficacy of Reslizumab in Patients with Poorly Controlled Eosinophilic Asthma: Subgroup Analysis of Patients with Nasal Polyps , 2011 .
[3] D. Hamilos,et al. Are we closer to understanding the pathophysiology of chronic rhinosinusitis? , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[4] Parameswaran Nair,et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. , 2009, The New England journal of medicine.
[5] W. Fokkens,et al. Inflammation in chronic rhinosinusitis and nasal polyposis. , 2009, Immunology and allergy clinics of North America.
[6] Ana Sousa,et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. , 2009, The New England journal of medicine.
[7] F. Levi-Schaffer,et al. Review: Tissue remodeling and angiogenesis in asthma: the role of the eosinophil , 2008, Therapeutic advances in respiratory disease.
[8] K. Takatsu,et al. IL-5 and eosinophilia. , 2008, Current opinion in immunology.
[9] E. Bleecker,et al. Assessing productivity loss and activity impairment in severe or difficult-to-treat asthma. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[10] W. Busse,et al. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. , 2007, American journal of respiratory and critical care medicine.
[11] C. Bachert,et al. Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. , 2006, The Journal of allergy and clinical immunology.
[12] C. Bachert,et al. Pathogenesis of chronic rhinosinusitis , 2006, Current allergy and asthma reports.
[13] L. Boulet,et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations , 2006, European Respiratory Journal.
[14] N. Bateman,et al. Activated eosinophils in nasal polyps: a comparison of asthmatic and non‐asthmatic patients , 2005, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.
[15] Klas Svensson,et al. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. , 2005, Respiratory medicine.
[16] E. Israel,et al. Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids. , 2005, The Journal of allergy and clinical immunology.
[17] D. Postma,et al. Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study. , 2003, American journal of respiratory and critical care medicine.
[18] I. Pavord,et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.
[19] P Godard,et al. Costs of asthma are correlated with severity: a 1-yr prospective study , 2002, European Respiratory Journal.
[20] K. Chung,et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response , 2000, The Lancet.
[21] R. Egan,et al. Effect of Sch 55700, a Humanized Monoclonal Antibody to Human Interleukin-5, on Eosinophilic Responses and Bronchial Hyperreactivity , 1999, Arzneimittelforschung.
[22] L. Boulet,et al. Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[23] G H Guyatt,et al. Development and validation of a questionnaire to measure asthma control. , 1999, The European respiratory journal.
[24] B. Wallaert,et al. Eosinophilic airway inflammation in nasal polyposis. , 1999, The Journal of allergy and clinical immunology.
[25] I. Pavord,et al. The use of induced sputum to investigate airway inflammation. , 1997, Thorax.
[26] C. Bachert,et al. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. , 1997, Journal of immunology.
[27] J. Bousquet,et al. Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.